Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Cefixime
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD
- Strength
- 200 mg/5 mL
- Dosage form
- Suspension
- Pack
- 30ml
- Registration no.
- 048415
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Mediate Pharmaceutical Pvt Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Hispan DS 200 mg/5 mL suspension
Hispan DS 200 mg/5 mL suspension contains Cefixime 200 mg/5 mL. It is registered with DRAP by Mediate Pharmaceutical Pvt Ltd (registration no. 048415). Its official price is PKR 366.45 for a pack of 30ml. This price has applied since 27 January 2026. 60 other brands of Cefixime 200 mg/5 mL (suspension) are registered in Pakistan. Compare all brands and prices →
Other brands of Cefixime 200 mg/5 mL
Official price over time
No change in the official DRAP price is recorded for this pack (30ml). Current price PKR 366.45, effective 27 Jan 2026.
Cite this price history
MedInfoBase. Hispan DS 200 mg/5 mL, 30ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/hispan-ds-200-mg-5-ml-048415-30ml-mediate-pharmaceutical-pvt-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 366.45 | 2026-01-27 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 048415Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
